AIM
PBYI icon

Assured Investment Management’s Puma Biotechnology PBYI Stock Holding History

Assured Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,443
Closed -$832K – 614
2019
Q1 		$832K Buy
21,443
+19,001
+778% +$580K 0.01% 429
2018
Q4 		$50K Buy
+2,442
New +$73.3K ﹤0.01% 1040
2016
Q2 		– Sell
-2,396
Closed -$70K – 656
2016
Q1 		$70K Buy
2,396
+581
+32% +$26.3K ﹤0.01% 552
2015
Q4 		$142K Buy
+1,815
New +$142K ﹤0.01% 513
2015
Q3 		– Sell
-2,392
Closed -$279K – 691
2015
Q2 		$279K Buy
+2,392
New +$433K ﹤0.01% 451

Other funds holding PBYI

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Assured Investment Management's PBYI Position: Q2 2019 in Review

Assured Investment Management sold out of Puma Biotechnology (PBYI) in Q2 2019, closing a stake of 21,443 shares — an estimated $832K sold.

Assured Investment Management first reported a position in PBYI in Q2 2015 and held it in 5 quarters. The position peaked at $832K in Q1 2019. 139 funds tracked by Wall St. Rank hold PBYI as of Q2 2019.

  • Assured Investment Management reported no remaining Puma Biotechnology position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 21,443 Puma Biotechnology shares in Q2 2019, an estimated $832K.
  • Assured Investment Management first reported a position in Puma Biotechnology in Q2 2015 and held it in 5 quarters.
  • Assured Investment Management's Puma Biotechnology position peaked at $832K in Q1 2019.
  • 139 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.